GLAXOSMITHKLINE - Bullish Flag & Pole Breakout (Daily T/F)Trade Setup
📌 Stock: GLAXOSMITHKLINE PHARMA ( NSE:GLAXO )
📌 Trend: Strong Bullish Momentum
📌 Risk-Reward Ratio: 1:3 (Favorable)
🎯 Entry Zone: ₹3417.65 (Breakout Confirmation)
🛑 Stop Loss: ₹3243.00 (Daily Closing Basis) (-5.25% Risk)
🎯 Target Levels:
₹3515.25
₹3611.70
₹3712.85
₹3813.30
₹3934.50 (
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
56.10 INR
9.28 B INR
37.49 B INR
39.61 M
About GlaxoSmithKline Pharmaceuticals Limited
Sector
Industry
CEO
Bhushan Akshikar
Website
Headquarters
Mumbai
Founded
1924
ISIN
INE159A01016
FIGI
BBG000CRN7T4
GlaxoSmithKline Pharmaceuticals Ltd. engages in the business of manufacturing, distributing and trading in pharmaceuticals. Its prescription medicines range across therapeutic areas such as anti-infective, dermatology, gynecology, diabetes, cardiovascular disease and respiratory diseases. The vaccines products include prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenza, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia and others. The company was founded in 1924 and is headquartered in Mumbai, India.
Related stocks
GLAXO SMITHKLINE PHARMA LTDAs of May 29, 2025, GlaxoSmithKline Pharmaceuticals Ltd. (NSE: GLAXO) is trading at ₹3,348.20, reflecting a 7.38% increase over the previous close.
📊 Daily Support & Resistance Levels
Based on the latest technical analysis, the key support and resistance levels are:
Support Levels:
S1: ₹3,174.33
GSK Pharma - Chart of the MonthNSE:GLAXO has a beautiful structure on the Monthly Timeframe to Qualify for my Chart of the Month idea, it saw Heavy Volumes around the marked Key Levels which broke out and retested went to ATM and Again Retested and Bounced from that Place With Volumes in Last Month.
Also if we Use Fibonacci ret
Glaxosmithkline pharma looking good for swing tradingSwing Trade
Glaxosmithkline pharma looking godd above 2615. the stock price has retested its monthly breakout zone and has taken a strong bounce followed by a consolidation breakout.
Entry: Above 2615
SL: 2417
TGT: 2755, 2913, 3157
Enter with only 50% quantity as we are against the market sentiments
Amazing breakout on WEEKLY Timeframe - GLAXOCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favor that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPECTED!
NOTE for learners: Place the break
GLAXO Price action analysisBased on the recent price action, GlaxoSmithKline Pharmaceuticals Ltd (GLAXO) is showing a strong bullish trend:
1. The stock surged 11.82% on February 18, 2025, closing at ₹2,608 after touching an intraday high of ₹2,744.95.
2. GLAXO has experienced a remarkable 29% gain over two consecutive trad
GLAXO (Breakout Stock)GlaxoSmithKline Pharmaceuticals Ltd. is showing strong technical momentum and is trading near a breakout level. Investors may keep this stock on their watchlist for potential movement.
Disclaimer: This is purely for informational purposes and not a recommendation to buy or sell. Investors are advis
GLAXO - bullish pennant - Watchlist if market recovers### GlaxoSmithKline (GSK) Stock Overview
GlaxoSmithKline plc (GSK), headquartered in Brentford, London, is a global healthcare company focused on pharmaceuticals, vaccines, and consumer healthcare products. Established through the merger of Glaxo Wellcome and SmithKline Beecham in 2000, GSK has a r
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GLAXO is 2,770.30 INR — it has decreased by −1.75% in the past 24 hours. Watch GlaxoSmithKline Pharmaceuticals Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GlaxoSmithKline Pharmaceuticals Limited stocks are traded under the ticker GLAXO.
GLAXO stock has risen by 1.85% compared to the previous week, the month change is a −0.79% fall, over the last year GlaxoSmithKline Pharmaceuticals Limited has showed a −2.76% decrease.
We've gathered analysts' opinions on GlaxoSmithKline Pharmaceuticals Limited future price: according to them, GLAXO price has a max estimate of 3,500.00 INR and a min estimate of 2,600.00 INR. Watch GLAXO chart and read a more detailed GlaxoSmithKline Pharmaceuticals Limited stock forecast: see what analysts think of GlaxoSmithKline Pharmaceuticals Limited and suggest that you do with its stocks.
GLAXO reached its all-time high on Jun 5, 2025 with the price of 3,515.70 INR, and its all-time low was 110.00 INR and was reached on Sep 27, 2001. View more price dynamics on GLAXO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
GLAXO stock is 3.51% volatile and has beta coefficient of 0.76. Track GlaxoSmithKline Pharmaceuticals Limited stock price on the chart and check out the list of the most volatile stocks — is GlaxoSmithKline Pharmaceuticals Limited there?
Today GlaxoSmithKline Pharmaceuticals Limited has the market capitalization of 481.21 B, it has decreased by −0.56% over the last week.
Yes, you can track GlaxoSmithKline Pharmaceuticals Limited financials in yearly and quarterly reports right on TradingView.
GlaxoSmithKline Pharmaceuticals Limited is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
GlaxoSmithKline Pharmaceuticals Limited revenue for the last quarter amounts to 8.05 B INR, despite the estimated figure of 8.84 B INR. In the next quarter, revenue is expected to reach 10.68 B INR.
GLAXO net income for the last quarter is 2.05 B INR, while the quarter before that showed 2.63 B INR of net income which accounts for −22.01% change. Track more GlaxoSmithKline Pharmaceuticals Limited financial stats to get the full picture.
Yes, GLAXO dividends are paid annually. The last dividend per share was 42.00 INR. As of today, Dividend Yield (TTM)% is 1.48%. Tracking GlaxoSmithKline Pharmaceuticals Limited dividends might help you take more informed decisions.
GlaxoSmithKline Pharmaceuticals Limited dividend yield was 1.46% in 2024, and payout ratio reached 76.71%. The year before the numbers were 1.65% and 91.89% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 5, 2025, the company has 3.11 K employees. See our rating of the largest employees — is GlaxoSmithKline Pharmaceuticals Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GlaxoSmithKline Pharmaceuticals Limited EBITDA is 11.98 B INR, and current EBITDA margin is 31.73%. See more stats in GlaxoSmithKline Pharmaceuticals Limited financial statements.
Like other stocks, GLAXO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GlaxoSmithKline Pharmaceuticals Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GlaxoSmithKline Pharmaceuticals Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GlaxoSmithKline Pharmaceuticals Limited stock shows the buy signal. See more of GlaxoSmithKline Pharmaceuticals Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.